NASDAQ:GLMD   Galmed Pharmaceuticals Ltd
$GLMD - Galmed Pharmaceuticals Ltd . - Ordinary Shares
Initial Alert Price: $3.67
Potential Price: $4.32
Potential Gains: 17.71
Stop Loss Limit: $

GLMD is working to retest the $4.32 Levels of Resistance and if it's able to breakthrough and we find support at those price levels, we can expect this to move forward in retesting the $5.15 Price Ranges. The company is currently conducting Phase 3 Trials for their drug Aramchol, which focuses on Non-Alcoholic Steatohepatitis and Liver Fibrosis. The company also has a 2nd Drug in Phase 3 Trials, Amilo-5MER for Chronic Inflammatory Disorders. The company will be hosting a symposium to give an update on the pipeline for the continued development, progress of clinical trials, and manufacturing/distribution moving into the future. #Breakout #Stocks #Trading #Investing #Alerts #StockMarket #Daily #News #Today